Immune complexes suppress IFN-γ-induced responses in monocytes by activating discrete members of the SRC kinase family

Journal of Immunology

Volumn 194, Issue 3, 2015, Pages 983-989

  Boekhoudt, Gunther H ^a   McGrath, Anna G ^a   Swisher, Jennifer F A ^a   Feldman, Gerald M ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC GAMMA RECEPTOR I; FC RECEPTOR; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; PROTEIN KINASE LYN; PROTEIN KINASE SYK; SMALL INTERFERING RNA; STAT1 PROTEIN; UNCLASSIFIED DRUG; ANTIGEN ANTIBODY COMPLEX; GAMMA INTERFERON INDUCIBLE PROTEIN 10; PROTEIN TYROSINE KINASE;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOREGULATION; MONOCYTE; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; CELL CULTURE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; PHOSPHORYLATION;

ANTIGEN-ANTIBODY COMPLEX; CELLS, CULTURED; CHEMOKINE CXCL10; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-GAMMA; MONOCYTES; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; STAT1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC;

EID: 84921482984     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401649     Document Type: Article

References (34)

1. Boehm, U., T. Klamp, M. Groot, and J. C. Howard. 1997. Cellular responses to interferon-γ. Annu. Rev. Immunol. 15: 749-795.
2. Shirayoshi, Y., P. A. Burke, E. Appella, and K. Ozato. 1988. Interferon-induced transcription of a major histocompatibility class I gene accompanies binding of inducible nuclear factors to the interferon consensus sequence. Proc. Natl. Acad. Sci. USA 85: 5884-5888.
3. Mach, B., V. Steimle, E. Martinez-Soria, and W. Reith. 1996. Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 14: 301-331.
4. Young, H. A., and K. J. Hardy. 1995. Role of interferon-gamma in immune cell regulation. J. Leukoc. Biol. 58: 373-381.
5. Biron, C. A., K. B. Nguyen, G. C. Pien, L. P. Cousens, and T. P. Salazar-Mather. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17: 189-220.
6. Igarashi, K., M. David, A. C. Larner, and D. S. Finbloom. 1993. In vitro activation of a transcription factor by g interferon requires a membrane-associated tyrosine kinase and is mimicked by vanadate. Mol. Cell. Biol. 13: 3984-3989.
7. Darnell, J. E., Jr., I. M. Kerr, and G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264: 1415-1421.
8. Ihle, J. N. 1996. STATs: signal transducers and activators of transcription. Cell 84: 331-334.
9. Pearl, J. E., B. Saunders, S. Ehlers, I. M. Orme, and A. M. Cooper. 2001. Inflammation and lymphocyte activation during mycobacterial infection in the interferon-γ-deficient mouse. Cell. Immunol. 211: 43-50.
10. van den Broek, M. F., U. Müller, S. Huang, M. Aguet, and R. M. Zinkernagel. 1995. Antiviral defense in mice lacking both a/b and g interferon receptors. J. Virol. 69: 4792-4796.
11. Jouanguy, E., S. Lamhamedi-Cherradi, D. Lammas, S. E. Dorman, M. C. Fondanèche, S. Dupuis, R. Döffinger, F. Altare, J. Girdlestone, J. F. Emile, et al. 1999. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat. Genet. 21: 370-378.
12. Mannik, M. 1982. Pathophysiology of circulating immune complexes. Arthritis Rheum. 25: 783-787.
13. Nimmerjahn, F., and J. V. Ravetch. 2005. Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science 310: 1510-1512.
14. Nimmerjahn, F., and J. V. Ravetch. 2008. Fcg receptors as regulators of immune responses. Nat. Rev. Immunol. 8: 34-47.
15. Bruhns, P., B. Iannascoli, P. England, D. A. Mancardi, N. Fernandez, S. Jorieux, and M. Daëron. 2009. Specificity and affinity of human Fcg receptors and their polymorphic variants for human IgG subclasses. Blood 113: 3716-3725.
16. Esparza, I., R. Green, and R. D. Schreiber. 1983. Inhibition of macrophage tumoricidal activity by immune complexes and altered erythrocytes. J. Immunol. 131: 2117-2121.
17. Virgin, H. W., IV, G. F. Wittenberg, and E. R. Unanue. 1985. Immune complex effects on murine macrophages. I. Immune complexes suppress interferon-gamma induction of Ia expression. J. Immunol. 135: 3735-3743.
18. Boekhoudt, G. H., M. R. Frazier-Jessen, and G. M. Feldman. 2007. Immune complexes suppress IFN-γ signaling by activation of the FcgRI pathway. J. Leukoc. Biol. 81: 1086-1092.
19. Feldman, G. M., E. J. Chuang, and D. S. Finbloom. 1995. IgG immune complexes inhibit IFN-γ-induced transcription of the FcgRI gene in human monocytes by preventing the tyrosine phosphorylation of the p91 (Stat1) transcription factor. J. Immunol. 154: 318-325.
20. Liuzzo, G., A. N. Vallejo, S. L. Kopecky, R. L. Frye, D. R. Holmes, J. J. Goronzy, and C. M. Weyand. 2001. Molecular fingerprint of interferon-γ signaling in unstable angina. Circulation 103: 1509-1514.
21. Nagarajan, U. M., J. Lochamy, X. Chen, G. W. Beresford, R. Nilsen, P. E. Jensen, and J. M. Boss. 2002. Class II transactivator is required for maximal expression of HLA-DOB in B cells. J. Immunol. 168: 1780-1786.
22. Winer, J., C. K. Jung, I. Shackel, and P. M. Williams. 1999. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal. Biochem. 270: 41-49.
23. Thomas, S. M., and J. S. Brugge. 1997. Cellular functions regulated by Src family kinases. Annu. Rev. Cell Dev. Biol. 13: 513-609.
24. Okun, E., M. P. Mattson, and T. V. Arumugam. 2010. Involvement of Fc receptors in disorders of the central nervous system. Neuromolecular Med. 12: 164-178.
25. Takai, T. 2005. Fc receptors and their role in immune regulation and autoimmunity. J. Clin. Immunol. 25: 1-18.
26. Blank, U., P. Launay, M. Benhamou, and R. C. Monteiro. 2009. Inhibitory ITAMs as novel regulators of immunity. Immunol. Rev. 232: 59-71.
27. Dunn-Siegrist, I., O. Leger, B. Daubeuf, Y. Poitevin, F. Dépis, S. Herren, M. Kosco-Vilbois, Y. Dean, J. Pugin, and G. Elson. 2007. Pivotal involvement of Fcg receptor IIA in the neutralization of lipopolysaccharide signaling via a potent novel anti-TLR4 monoclonal antibody 15C1. J. Biol. Chem. 282: 34817-34827.
28. Pinheiro da Silva, F., M. Aloulou, D. Skurnik, M. Benhamou, A. Andremont, I. T. Velasco, M. Chiamolera, J. S. Verbeek, P. Launay, and R. C. Monteiro. 2007. CD16 promotes Escherichia coli sepsis through an FcRg inhibitory pathway that prevents phagocytosis and facilitates inflammation. Nat. Med. 13: 1368-1374.
29. Baker, S. J., S. G. Rane, and E. P. Reddy. 2007. Hematopoietic cytokine receptor signaling. Oncogene 26: 6724-6737.
30. Jatiani, S. S., S. J. Baker, L. R. Silverman, and E. P. Reddy. 2010. Jak/STAT pathways in cytokine signaling and myeloproliferative disorders: approaches for targeted therapies. Genes Cancer 1: 979-993.
31. Lowell, C. A. 2011. Src-family and Syk kinases in activating and inhibitory pathways in innate immune cells: signaling cross talk. Cold Spring Harb. Perspect. Biol. 3.
32. van der Poel, C. E., R. A. Karssemeijer, P. Boross, J. A. van der Linden, M. Blokland, J. G. van de Winkel, and J. H. W. Leusen. 2010. Cytokine-induced immune complex binding to the high-affinity IgG receptor, FcgRI, in the presence of monomeric IgG. Blood 116: 5327-5333.
33. Pfirsch-Maisonnas, S., M. Aloulou, T. Xu, J. Claver, Y. Kanamaru, M. Tiwari, P. Launay, R. C. Monteiro, and U. Blank. 2011. Inhibitory ITAM signaling traps activating receptors with the phosphatase SHP-1 to form polarized "inhibisome" clusters. Sci. Signal. 4: ra24.
34. Bezbradica, J. S., R. K. Rosenstein, R. A. DeMarco, I. Brodsky, and R. Medzhitov. 2014. A role for the ITAM signaling module in specifying cytokine-receptor functions. Nat. Immunol. 15: 333-342.